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Abstract
Aberrant activation of caspase-6 has recently emerged as a major contributor to the pathogeneses of neurodegenerative
disorders such as Alzheimer’s and Huntington disease. Commercially available assays to measure caspase-6 activity
commonly use the VEID peptide as a substrate. However these methods are not well suited to specifically assess caspase-6
activity in the presence of other, confounding protease activities, as often encountered in cell and tissue samples. Here we
report the development of a method that overcomes this limitation by using a protein substrate, lamin A, which is highly
specific for caspase-6 cleavage at amino acid 230. Using a neo-epitope antibody against cleaved lamin A, we developed an
electrochemiluminescence-based ELISA assay that is suitable to specifically detect and quantify caspase-6 activity in highly
apoptotic cell extracts. The method is more sensitive than VEID-based assays and can be adapted to a high-content imaging
platform for high-throughput screening. This method should be useful to screen for and characterize caspase-6 inhibitor
compounds and other interventions to decrease intracellular caspase-6 activity for applications in neurodegenerative
disorders.
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Introduction
Proteases of the caspase family are known as important
mediators of apoptosis and have been commonly subdivided
based on their roles in apoptosis or inflammation (apoptotic
initiator, apoptotic executioner or inflammatory caspases). This
definition however has become somewhat inaccurate as an
increasing number of non-apoptotic roles for both initiator and
executioner caspases have been identified that mediate cell
differentiation, maturation and signaling events [1].
Caspases can further be distinguished based on their inherent
differences in caspase substrate preference that are defined by the
shape and electrostatic potential of the active site cleft [2]. Using
positional scanning of peptide libraries, consensus recognition
sequences have been proposed for each caspase and have led to
the development of peptide substrates as well as inhibitors that
typically consist of 4 amino acids (i.e. DEVD for caspase-3),
followed by a fluorescent tag such as Afc (7-amino-4-trifluoro
methylcoumarin) for a substrate or a ‘warhead’ such as fmk
(fluoromethylketone) that covalently binds the enzyme for an
inhibitor. These reagents are useful to investigate caspases that
constitute the majority of caspase-like activity in a sample, as it
may be assumed for active caspase-3 in highly apoptotic extracts
[3]. However, with Km/kcat ratio differences of less than 10 fold
for many widely used peptide substrates [4], these reagents are not
particularly useful for investigating the activity of a caspase present
at lower concentrations in cell culture and tissue samples. In
particular in developmental or signalling processes that do not
involve cell death, intracellular caspase activity is likely under tight
control by endogenous caspase inhibitors or the proteasome [5,6]
and the resulting low levels of activity are difficult to detect with
peptide substrates.
In biologic protease substrates, additional factors outside the 4
amino acid recognition site can influence the selectivity and
efficiency of proteolytic cleavage. For caspases, it has been shown
that the amino acid residue directly after the scissile bond (P19)i s
an important determinant of cleavage, since charged or bulky
residues are not well tolerated [7]. Furthermore, domains far away
from the cleavage site can mediate the interaction between
substrate and protease (exosites), and although such interactions
have not yet been shown for proteases of the caspase family, the
high variability of cleavage site motifs in natural caspase substrates
argues in favour of the presence of exosites. Known substrates for
caspase-6 show a particularly high variability in their recognition
sequences [8], with cleavage sites other than I/D/E/L/T/V, E/
D/Q, X, D found in substrates such as the presenilins (ENDD,
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27680[9]), huntingtin (IVLD, [10]), DNA Topoisomerase I (PEDD,
[11]), AP-2 alpha (DRHD, [12]), Periplakin (TVAD, [13]), FAK
(VSWD, [14]) and TGEV (VVPD, [15]).
Caspase-6 has garnered much attention recently since it has been
shown that it is involved in the developmental pruning of axons
[16,17], and it has been suggested that similar pathways might
erroneously be activated in neurodegenerative disorders such as
Alzheimer’s (AD) and Huntington disease (HD) [16,18]. The
presence of activated caspase-6 and cleavage of caspase-6 substrates
is indeed a hallmark of AD, HD and cerebral ischemia, and has
been shown in a number of different animal models and patient
brain tissue [18,19,20,21,22]. To assess caspase-6 activity in cell and
tissue samples, peptide substrates or inhibitors need to be titrated
accurately to yield meaningful results, since the peptide substrate
commonly used to assess caspase-6 activity, VEID, can be cleaved
by other caspases as well as the proteasome when used at too high
concentrations [23,24]. In addition, even low concentrations of a
VEID substrate can lead to inaccurate results if the relative amount
of other proteolytic activity in the sample is significantly higher than
that of caspase-6dueto small differencesin kcat/Km [4]. A recently
developed method using the biotinylated caspase inhibitor zVAD is
significantly more specific, but to achieve this specificity, immuno-
precipitation and subsequent detection of the active caspase by
Western blotting is required [23]. For a more quantitative way of
assessing caspase-6-specific activity, we have developed a novel
method based on the cleavage of lamin A [24]. Here we show that
this method is sensitive, specific and allows for the detection of
caspase-6 activity in complex samples. The assay quantitatively
measures caspase-6 activity and can be useful for investigating
caspase-6 biology as well as the screening and intracellular efficacy
assessment of caspase-6 inhibitors.
Results
In order to develop an activity assay that is more specific for
caspase-6 than available methods relying on the cleavage of the
VEID peptide, we decided to investigate the cleavage of known
caspase-6 substrates. To be useful for the measurement of caspase-
6 activity, a substrate would ideally be as specific as possible. In
particular it should not be cleaved by other proteases activated
during apoptosis and be cut by caspase-6 in detectable quantities.
The protein substrate should be easy to purify and thus available
in larger amounts, and existing neo-epitope antibodies allowing for
the specific detection of the cleavage fragment would be an
advantage. The nuclear lamin proteins were among the first
caspase-6 substrates characterized [25], and knockdown studies
strongly suggest that their cleavage during apoptosis is highly
dependent on the presence of caspase-6 [24]. Furthermore,
purified lamin A as well as a variety of neo-epitope antibodies
against the cleavage fragments are readily available, and high
stability of the cleavage fragments without further degradation
during the apoptotic process has been described [26] , which
should facilitate their detection.
The VEID peptide sequence commonly used in caspase-6
substrates and inhibitors is derived from the lamin cleavage site,
but since protein context is known to change the kinetics and
specificity of proteolytic events, we decided to compare the
cleavage of the VEID peptide to that of the full-length lamin A
protein.
The lamin A protein is a more specific substrate than its
VEID peptide
We therefore decided to investigate whether lamin A is a
specific substrate for caspase-6. In particular, we were interested in
the ability of other executioner caspases to cleave lamin A, since
these are likely to show high activity in apoptotic extracts where
accurate quantification of caspase-6 activity will be of interest. We
first subjected the Ac-VEID-AFC substrate to digestion by
caspases -3, -6 and -7, respectively. The amount of active enzyme
used in each reaction was normalized to the concentration of
active sites in the sample as determined by titration against the
irreversible inhibitor zVAD-fmk (Fig. S1). As expected, the VEID
peptide substrate, although it is best processed by caspase-6, still
shows significant cleavage by caspase-3 and -7 (Fig. 1A) at high
substrate concentrations (100 mM). Lower substrate concentrations
can be used to achieve greater specificity, however, the difference
in kcat/Km for VEID is less than 3 fold between caspase -3 and -6
[4]. This results in a small concentration window that can be
exploited to achieve selectivity for caspase-6, if the same amounts
of active caspase-3 and -6 are present. However, this window will
be lost if the sample contains a higher concentration of active
caspase-3 than caspase-6. As shown in Figure 1B, an 8 fold molar
excess of caspase-3 over caspase-6 is enough to lead to a
significantly higher signal from the non-specific caspase-3, making
VEID-based assays problematic for the use in apoptotic samples or
other cell and tissue lysates with high levels of active caspase-3.
Lamin A, on the other hand, only showed proteolytic processing
when incubated with recombinant active caspase-6, not with the
corresponding amounts of caspases -3 and -7 at concentrations up
to 300 mM (Fig. 1C). We therefore focussed on lamin A as a
substrate for the development of a specific caspase-6 activity assay.
To confirm the selectivity of lamin cleavage by caspase-6, we
made use of mouse embryonic fibroblast (MEF) cells generated
from wild-type and caspase-62/2 (C6wt and C6ko) mice [27].
These cells only differ in their expression of caspase-6 (Fig. 2A),
making them an ideal system to study the specificity of caspase-6
substrates. Apoptosis was induced by the addition of 50 nM
staurosporine to the culture medium, and the activation of
caspase-6 was monitored over time by assessing the cleavage of
endogenous lamin A via Western blotting (Fig. 2B) or with the Ac-
VEID-AFC peptide substrate (Fig. 2F). The antibody used to
detect full length lamin A at 70 kDa cross-reacts with the closely
related lamin C protein (60 kDa, [28]), and the N-terminal
fragments of both cleaved lamin A and C are detected at the same
size of 28 kDa (Fig. 2B+E). Furthermore, using a cell line that does
not express caspase-3 but expresses caspase-6 (Fig. 2C), we found
that the lamin proteins are still processed after the induction of
apoptosis with camptothecin (Fig. 2D), confirming the require-
ment of caspase-6 but not caspase-3 for this process.
An increase in VEID cleavage over time was observed for both
C6wt and C6ko cell lines (Fig. 2F). For C6wt cells, significant
increases over baseline were observed at all time points, whereas
the C6ko cells show lower VEID processing initially with a non-
significant increase in the first 2 h of treatment. However, at later
timepoints C6ko cells exhibit similar levels of VEID cleavage as
C6wt with a highly significant increase over non-treated controls
(Fig. 2F), suggesting that other proteases make up for a large
proportion of the VEID cleavage activity in apoptotic extracts.
These results indicate that the lamin protein substrates are much
more specific for cleavage by caspase-6 than the VEID peptide.
Development of an electrochemiluminescence-based
ELISA method for the quantitative assessment of cleaved
lamin A
In order to accurately quantitate the amount of cleaved lamin A
generated by caspase-6, we turned to an ELISA-based assay
format using the MesoscaleH platform, which allows for a fast and
sensitive detection with minimal background using electrochemi-
Caspase-6 Activity Assessment in Cell Culture
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more sensitive than cleavage of the VEID peptide substrate in
detecting low levels of active caspase-6, we incubated different
concentrations of the enzyme in parallel either with Ac-VEID-
AFC or purified lamin A protein and determined the amount of
cleavage after 30 min by measuring the fluorescence in the sample
(for Ac-VEID-AFC) or by subjecting the sample to an ELISA
using the lamin A neo-epitope antibody (for lamin A cleavage).
Comparison of the results showed that both assays perform at least
equally well in detecting active caspase-6 concentrations down to
10 nM, with the lamin cleavage assay showing a linear
concentration-response relationship down to the lowest caspase
concentrations tested (Fig. 3A). Signal-to-noise ratios were at or
above 3 for the ELISA assay for as low as 10 nM caspase-6,
whereas the signal-to-noise dropped below 3 for the VEID-based
assay at this concentration (Fig. 3B). Using a peptide inhibitor for
caspase-6, VEID-CHO, both assays furthermore arrived at a
similar IC50 value (lamin-based ELISA: 64620 nM, VEID-based
assay: 5666 nM), indicating that the ELISA method is suitable to
assess the inhibition of caspase-6 by small molecules or peptides.
Overall, our method shows a slight increase in sensitivity over
commonly used VEID cleavage methods and is able to reliably
detect caspase-6 concentrations down to 10 nM.
Next, we wanted to assess whether the lamin cleavage assay
shows higher specificity than the VEID-based system for caspase-6
over other proteases that are activated after induction of apoptosis.
To this end, we tested lysates derived from staurosporine-stressed
C6wt and C6ko MEFs with our newly developed ELISA and
found a linear increase in signal over time in wt samples, whereas
the signal from C6ko samples remained stable at background
levels that were similar to the background seen in untreated C6wt
(Fig. 3D). This indicates that the amount of intracellularly cleaved,
Figure 1. The lamin A protein is a more specific substrate than its VEID peptide. A: 100 mM VEID-Afc was incubated with different amounts
of caspase -3, -6 or -7 for 1 h at 37uC. Fluorescence generated by cleavage was monitored over time, and the initial, linear portion of the curve was
used to calculate the reaction velocity. VEID is preferentially cleaved by caspase-6, but also cross-reacts with caspases -3 and -7 at higher
concentrations. Error bars are the SEM of N$3 of 3 independent experiments. B: 5 mM VEID-Afc was incubated with 0.5 mM caspase-6 or different
amounts of caspase-3 for 1 h at 37uC. The reaction velocity was calculated as in A. Even at this low concentration of VEID-Afc, the peptide substrate
can be cleaved by caspase-3, and an 8 fold higher molar concentration of caspase-3 than caspase-6 results in a higher signal for VEID cleavage by
caspase-3 than caspase-6. Error bars are the SEM of N=3 independent experiments, statistical significance was assessed by 1-way ANOVA and post-
hoc Dunnett comparisons: *** p,0.0001. C: Pure lamin A protein was incubated with different amounts of caspase -3, -6 or -7 for 30 min at 37uC.
Samples were separated by SDS-PAGE and both fragments of cleaved lamin A was detected by Western blotting with antibodies #2031 (full-length
lamin A and N-terminal fragment) and #2032 (C-terminal fragment). No cleavage was observed with caspases -3 or -7, while caspase-6 generated
lamin A fragments in a dose-dependent manner. A representative image of 3 independent experiments is shown.
doi:10.1371/journal.pone.0027680.g001
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quantification of caspase-6 activated during staurosporine-induced
apoptosis.
Kinetic measurements of either Ac-VEID-AFC or lamin A
cleavage by fluorescence or our newly developed ELISA allowed
comparison of the kinetic parameters of caspase-6 for the two
substrates. We find that the full-length lamin A protein has a more
than 1000fold lower Km than its cleavage site peptide VEID
(Table 1). Although the kcat value is also decreased, the kcat/Km
is still more than 10fold higher for lamin A (Table 1). This
indicates that the binding between lamin A and caspase-6 is
tighter, which might be mediated by domains outside the cleavage
site. Such binding sites could also be responsible for the observed
specificity of caspase-6 for the full-length protein substrate. The
Km and kcat values for VEID are furthermore in good agreement
with previously reported data [4].
Quantitation of caspase-6 activity in neuronal lysates
Caspase-6 is postulated to be involved in neuronal degeneration
and apoptosis [16,17,18,20,22,30], and detection of its activity in
neuronal cultures is therefore of paramount interest. Previous
studies have frequently used TUNEL assays as a measure of
apoptosis, looked at VEIDase activity or the presence of the active
caspase-6 fragment by Western blotting or immunostaining and
assessed the presence of cleaved caspase-6 substrates
[8,18,20,21,22]. The most specific methods to assess the effect of
drug treatments on caspase-6 activity developed so far use
antibodies against the active caspase-6 fragment, levels of which
Figure 2. VEID, but not lamin A+C, is cleaved in the absence of caspase-6. A: Caspase-6 protein (full-length, 32 kDa) is detected in MEFs
generated from C6wt, but not C6ko mice. B: Endogenous lamin A protein (70 kDa) is cleaved in wt, but not C6ko MEFs after staurosporine stress for
4 h or longer. The antibody cross-reacts with full-length lamin C (60 kDa), and the cleaved band at 28 kDa has the same size for both lamin A+C
(lower panel). C: MCF-7 cells express caspase-6, but not caspase-3 protein, whereas both C6wt and C6ko MEFs contain both caspases. hu: human, m:
mouse, ns: non-specific band. D: MCF-7 cells were stressed with 5 mM camptothecin for different amounts of time and the cleavage of endogenous
lamin A and C proteins was monitored by Western blotting with antibodies antibodies #2031 (full-length lamin A+C) and #2032 (C-terminal
fragments). E: Schematic representation of lamin A and C and the caspase-6 cleavage site at AA 230. The N-terminal fragments generated by caspase-
6 cleavage (red) have the same size (28 kDa) for both lamin A+C. F: C6wt or C6ko MEFs were stressed with 50 nM staurosporine for different amounts
of time, lysates were generated and analyzed for cleavage of VEID-Afc. C6wt cells show a significant increase in fluorescence at each timepoint, the
fluorescence signal obtained from C6ko lysates only reach a statistically significant difference from baseline after 4 h. C6ko MEFs stressed with
staurosporine for 4 h or more show the same levels of VEID proteolysis as wt cells. Error bars are the SEM of N=3 of 4 independent experiments.
Statistical significance was assessed by 2-way ANOVA and post-hoc Bonferroni comparisons: *** p,0.0001, ** p,0.001, * p,0.01.
doi:10.1371/journal.pone.0027680.g002
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immunoprecipitation of active caspases with biotinylated zVAD-
fmk, which depends on efficient precipitation and Western blotting
for quantification [23].
Our newly developed ELISA method, however, could not be
directly applied to neuronal cultures, since lamin A is not
expressed in embryonic mouse brain [31]. Neurons in early stages
of development up until postnatal day 5 express lamins of the B1
and B2 subtypes, which differ from the lamin A and C sequence at
the caspase cleavage site (VEVD in B-type lamins and VEID in
lamins A and C (Fig. 4A) [24,31]). Furthermore, the cleavage of
lamins B1 and B2 at this site is not specific for caspase-6, as has
been shown in a caspase-6-deficient cell line [24]. In agreement
with these findings, we observed cleavage of lamin B1 in primary
cortical neurons derived from both C6wt and C6ko mice at
embryonic day 16.5 (Fig. 4B), while lamins A and C were not
detected (data not shown). To overcome this obstacle, we decided
to spike C6wt and C6ko neuronal lysates with purified lamin A
protein, and after incubation at 37uC to allow for its cleavage by
endogenous caspase-6 activity, we subjected the samples to our
ELISA assay. We detect a significant increase in cleavage of lamin
A protein when the incubation was performed in the presence of
extracts derived from camptothecin-stressed C6wt neurons,
whereas no increase in cleaved lamin A signal was observed in
the presence of camptothecin-stressed C6ko neuronal extracts
(Fig. 4C). The ELISA method is therefore also suitable to detect
caspase-6 activity in samples that do not contain endogenous
lamin A or C protein.
Detection of caspase-6 activity in the absence of
endogenous lamin cleavage
Caspase-6 activity can be localized to the nucleus, which is
commonly associated with cell death and the cleavage of nuclear
substrates such as lamin A, whereas a cytoplasmic localization of
active caspase-6 as it is the case in neurodegeneration does not
result in immediate apoptosis [5,21,32]. We therefore decided to
test whether spiking of cell extracts with pure lamin A protein can
detect active caspase-6 at early timepoints, before its translocation
Figure 3. Increased sensitivity and highly improved specificity in a lamin-based caspase-6 activity assay. A+B: Quantities of down to
10 nM active caspase-6 can be detected with the novel lamin A-based caspase-6 assay while maintaining a signal-noise ratio of .3. C: The peptide
inhibitor VEID-CHO shows a similar IC50 value in both the VEID- and the lamin A- based caspase-6 assays. D: The lamin A-based caspase-6 assay is
highly specific, with no signal generated from C6ko cells even after 6 h of staurosporine stress. Error bars are the SEM of N$3 of 3 independent
experiments. Statistical significance was assessed by 2-way ANOVA and post-hoc Bonferroni comparisons: *** p,0.0001, ** p,0.001.
doi:10.1371/journal.pone.0027680.g003
Table 1. Km and kcat values for caspase-6 substrates.
Km kcat kcat/Km
VEID 30.962.2 mM4 . 3 60.12 sec
21 139 200 M
21 sec
21
lamin A 14.1162.592 nM 0.05760.0025 sec
21 4 055 043 M
21 sec
21
doi:10.1371/journal.pone.0027680.t001
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we transiently transfected COS7 cells with full-length human
caspase-6, a system in which the enzyme auto-activates in the
cytosol before translocating to the nucleus [32]. After transfection,
the active form of caspase-6 becomes detectable by Western
blotting at the 9 h timepoint (Fig. 5A). After 24 h of incubation,
low levels of endogenous lamin A cleavage were observed with the
ELISA method, indicating that at this time point active caspase-6
is present in the nucleus (Fig. 5B). However, when cell lysates were
supplemented with purified lamin A protein and endogenous,
active caspase-6 was allowed to cleave the spiked protein, activity
could already be detected after 9 h and increased dramatically at
later time points (Fig. 5B), in agreement with the Western blot data
(Fig. 5A). This indicates that the spiking method can detect
caspase-6 activity before endogenous lamin is cleaved and is thus
suitable to detect non-nuclear caspase-6 activity.
High-throughput immunofluorescence measurements of
lamin A cleavage
Although our Mesoscale ELISA method shows significant
advantages over commonly used, VEID-based assay systems to
measure caspase-6 activity, it still requires manual cell lysis and
protein quantification steps that are not easily amenable to high-
throughput screening campaigns. We therefore turned to a high-
content imaging platform that allows automated liquid handling as
well as immunofluorescence imaging and quantification. Using a
primary antibody specific for caspase-6 cleaved lamin A, we found
Figure 4. Cleavage of lamin B1 in primary neuronal cultures is
not caspase-6 specific, but spiking with lamin A provides a
specific readout. A: Lamins B1 and B2 differ from lamins A and C in
their caspase cleavage site (VEVD versus VEID, respectively). B: Lamin B1
is cleaved after camptothecin stress in primary cortical neuronal
cultures derived from C6wt and C6ko mice. C: Spiking with lamin A
protein results in an increased ELISA signal in lysates from camptothe-
cin-stressed C6wt, but not C6ko neurons. Boxes represent the 25
th–75
th
percentile, whiskers represent the minimum and maximum. Data from 5
(C6ko) and 7 (C6wt) separate cultures are shown. Statistical significance
was assessed by 2-way ANOVA and post-hoc Bonferroni comparisons:
*** p,0.0001.
doi:10.1371/journal.pone.0027680.g004
Figure 5. Spiking with lamin A allows for the detection of
caspase-6 activity before the cleavage of endogenous lamins.
A: COS7 cells were transiently transfected with recombinant human
caspase-6 and cultured for the indicated amounts of time. The active
caspase-6 fragment can be observed by Western blotting 9 h after
transfection and is increasingly abundant after 24 h. B: COS7 cells were
transfected as in A. The cleavage of endogenous lamin A protein can be
observed with the ELISA method after 24 h, whereas spiking of lysates
with lamin A protein leads to a robust detection of caspase-6 activity
9 h after transfection. Statistical significance was assessed by 2-way
ANOVA and post-hoc Bonferroni comparisons: *** p,0.0001.
doi:10.1371/journal.pone.0027680.g005
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death by camptothecin (Fig. 6A). The observed blebbing of the
nuclear membrane is consistent with the breakdown of the nuclear
lamina during apoptosis. No staining for cleaved lamin protein was
observed in non-stressed C6wt, non-stressed C6ko or camptothe-
cin-stressed C6ko cells (Fig. 6A). Using nuclear DAPI staining as a
reference point, we quantified the perinuclear immunofluores-
cence in a ring around the nucleus (Fig. 6A, insets), and found a
2fold increase in staining intensity in camptothecin-stressed versus
non-stressed wt MEFs (Fig. 6B). Only background signal was
observed in C6ko MEFs even after camptothecin treatment,
indicating that the detection of cleaved lamin A by immunoflu-
orescence is also specific to caspase-6 (Fig. 6B). This method is
ideally suited for the high-throughput intracellular testing of
modulators of caspase-6 activity in in the presence of confounding
proteolytic activity, i.e. that of caspase-3.
Discussion
The study of the role of caspases during apoptosis, but also
during non-apoptotic developmental and signalling processes, is
hampered by the lack of specific assays to measure the activity of
single members of the caspase family. Neo-epitope antibodies
against the active forms of caspases are available and can be used
in immunohistochemical and Western blotting applications.
However, the presence of active caspase fragments does not
necessarily correlate with proteolytic activity, since the proteases
could be bound to either endogenous or exogenous inhibitors,
which is especially problematic in high-throughput screening
campaigns aiming to identify caspase inhibitors. Another method
using immunoprecipitation with biotinylated zVAD, on the other
hand, is specific to active caspases, but quantitation relies on the
efficacy of immunoprecipitation and Western blotting [23].
To be able to accurately quantify the activity of caspase-6 in cell
culture, we therefore developed novel activity assays based on the
cleavage of the caspase-6 specific substrate protein lamin A [24].
Here, we confirm the specificity of lamin A cleavage by caspase-6
using C6wt and C6ko MEFs that were stressed with staurosporine
to undergo apoptosis. Although the antibodies we used in this
study cross-react with cleaved lamin C, specificity for caspase-6
cleavage is maintained, since both proteins arise from the same
gene by alternative splicing, contain the same caspase-6 cleavage
site and only differ in their C-termini with lamin A being 10 kDa
longer (Fig. 2D) [28,33]. The cleaved fragment was detected in
C6wt, but not in C6ko MEFs, and we developed an electro-
chemiluminescence-based ELISA method to accurately quantify
cleaved lamin using the Mesoscale platform. The new method has
an improved detection limit and signal-noise ratio over commer-
cially available caspase-6 activity assays using the VEID peptide
substrate. Furthermore, our assay is specific to caspase-6 and thus
superior for the detection of caspase-6 activity in complex samples
with a variety of different proteolytic activities such as cell lysates.
Through spiking with purified lamin A protein, the assay can be
applied to samples lacking endogenous lamin A and C such as
embryonic primary neurons. Furthermore, the method is amena-
ble to samples where caspase-6 activity does not lead to the
cleavage of the endogenous nuclear lamins and is therefore not
necessarily associated with apoptosis.
The specificity is due to the use of a protein instead of a peptide
substrate, and even though the VEID sequence is derived from the
caspase-6 cleavage site in lamin A (aa227–230), we show that the
Kcat/Km value for lamin A is more than 10fold higher than for
VEID, indicating that lamin A is a better substrate for caspase-6. A
similar effect has been shown for proteases involved in blood
Figure 6. Caspase-6 activity can be quantified by immunoflu-
orescent staining for cleaved lamin A. A: C6wt and C6ko MEFs
were stressed with camptothecin, stained with an antibody against
cleaved lamin A and analyzed on an automated imaging platform.
Nuclei were counterstained with DAPI, and identified by the software
(blue circles). Debris (red circles) was not analyzed. The signal intensity
in the cleaved lamin A channel was quantified in a ring around the
nucleus (green circles). B: Quantitation of the perinuclear staining from
cleaved lamin A is graphed. Untreated C6wt MEFs were normalized to
100% and the fold change in stressed C6wt, stressed and non-stressed
C6ko MEFs are compared. Error bars are the SEM of N$3o f3
independent experiments. Statistical significance was assessed by 2-
way ANOVA and post-hoc Bonferroni comparisons: *** p,0.0001.
doi:10.1371/journal.pone.0027680.g006
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site of the protease (exosite). There has been speculation about the
presence of exosites in caspases [36], but their existence has not
been proven conclusively yet. The example of exploiting protein
substrate specificity for the development of an activity assay could
be used for the development of more specific assays for other
members of the caspase family, such as p23 for caspase-7 [3].
Caspase-6 has recently emerged as an important player in
neuronal dysfunction and degeneration and its activation has been
linked to several neurodegenerative conditions such as AD, HD
and stroke [16,17,18,19,20,21,22,30,37]. Direct inhibition of the
enzyme as well as targeting of other players in the activation
pathway might therefore be beneficial in these disorders. We show
here that the cleavage of lamin A can be assessed in a high-
throughput setting using a high-content imaging platform, making
it an ideal intracellular readout to test interventions that decrease
caspase-6 activity.
Materials and Methods
All experiments were carried out in accordance with protocols
(Animal protocol A07-0106) approved by the UBC Committee on
Animal Care and the Canadian Council on Animal Care.
Ac-VEID-Afc, Ac-DEVD-Afc, Ac-VEID-CHO, zVAD-fmk
and active caspase-3, -6 and -7 enzymes were purchased from
Enzo Biosciences. Lamin A antibodies were from Cell Signaling
Technology: cleaved lamin A and total lamin A/C for Western
blotting (cat. nos. 2031 and 2032), cleaved lamin A for Mesoscale
ELISA (cat. no. 2036) and immunofluorescence staining (cat.
no. 2036). Pure lamin A protein and lamin B1 antibody were from
Abcam (cat. nos. ab8982 and ab83472), antibody against full-
length caspase-6 was from Cell Signaling Technology (cat.
no. 9762), antibody against caspase-3 was from Cell Signaling
Technology (cat. no. 9662), antibody against actin was from
Chemicon (cat. no. MAB1501R). Camptothecin and staurospor-
ine were from Sigma, cell culture reagents were from Gibco.
Activity assays using Ac-VEID-AFC and Ac-DEVD-AFC
The amounts of enzyme indicated in the figures (5–500 nM)
were incubated with 100 mM Ac-VEID-AFC at 37uC in caspase
cleavage buffer (50 mM HEPES pH 7.4, 100 mM NaCl, 0.1%
CHAPS, 1 mM EDTA, 10% glycerol, 10 mM DTT) for 1 h in a
black 96well plate (Nunc). Fluorescence was measured every 5 min
with excitation at 400 nm and emission at 505 nm. The initial
linear part of the curve was analyzed.
For the calculation of active site concentrations, Ac-DEVD-
AFC was used for caspases-3 and -7 according to the same
protocol, and different amounts of zVAD-fmk were added to all
reactions. The ratio between reaction velocity with inhibitor (Vi)
over reaction velocity without inhibitor (V0) was plotted against
the inhibitor concentration, and the concentration for y=0 was
determined as the active site concentration of the caspase.
The specific activity of the caspase enzymes used was
determined with a standard curve using free AFC and the Ac-
VEID-AFC or Ac-DEVD-AFC substrate for caspase-6 and
caspases -3 and -7, respectively. The resulting specific activities
were: 11.7 nmol Ac-VEID-AFC/min/mmol caspase-6, 13.7 nmol
Ac-DEVD-AFC/min/mmol caspase-3 and 9.9 nmol Ac-DEVD-
AFC/min/mmol caspase-7.
For the assessment of VEID cleavage in cell lysates, lysates
corresponding to 100 mg protein were mixed with an equal
volume 200 mM Ac-VEID-AFC in 26 caspase cleavage buffer.
Fluorescence was measured as described above.
Determination of Km and Kcat
Different concentrations of Ac-VEID-Afc substrate (1–150 mM)
were digested with 10 nM caspase-6 in caspase cleavage buffer for
1 h in a black 96well plate (Nunc). Fluorescence was measured
every 5 min with excitation at 400 nm and emission at 505 nm.
The initial linear part of the curve was analyzed.
Different concentrations of lamin A protein (3–400 nM) were
digested with 20 nM caspase-6 in caspase cleavage buffer for 15,
30, 45, and 60 minutes at 37uC. The reactions were stopped by
shock-freezing, and thawed samples were analysed with the
Mesoscale ELISA system. The cleavage rate was calculated at
each lamin concentration and plotted against the concentration of
Lamin A protein to calculate the Km and Kcat (Fig. S2).
Caspase-6 activity assays using the Mesoscale ELISA
system
100 ng pure lamin A protein was subjected to digestion by
different concentrations of caspase enzymes as indicated in the
figures (0.05–1000 nM) in caspase cleavage buffer for 30 min at
37uC. The reactions were stopped by shock-freezing, and thawed
samples were analysed with the Mesoscale ELISA system: 5 mlo f
each reaction, corresponding to 25 ng lamin A protein, were
spotted onto Mesoscale ELISA plates. Samples were incubated at
room temperature for 1 h, then 150 ml 5% BSA in PBS was added
per well and the plate was again incubated for 1 h at room
temperature. All wells were briefly washed 3 times with 150 ml
PBS containing 0.05% Tween-20, and 25 ml antibody mix was
added per well (cleaved lamin A antibody, Cell Signaling 2036,
1:100, goat anti-mouse sulfo-tag secondary antibody, MSD
technology, 1:500 in 1% BSA/PBS). After 1 h incubation at
room temperature, all wells were briefly washed 3 times with
150 ml PBS containing 0.05% Tween-20, and 150 ml2 6reading
reagent (MSD technology) was added per well. The plates were
then read on a Mesoscale platform electrochemiluminescence
reader (MSD technology) according to manufacturer’s instruc-
tions.
For assays using MEF or MCF-7 cell lysates, lysates were diluted
in PBS to 0.2 mg/ml, 5 ml were spotted in each well of a Mesoscale
ELISA plate and the plate was developed as described above.
For assays using neuronal or transfected COS7 cell samples,
lysates corresponding to 20 mg total protein were mixed with
100 ng lamin A protein in 16 caspase cleavage buffer. Samples
were incubated for 3 h at 37uC, 5 ml were spotted in each well of a
Mesoscale ELISA plate and the plate was developed as described
above.
Mouse embryonic fibroblast culture and lysis
Mouse embryonic fibroblasts (MEFs) from a C6ko mouse and
its C6wt littermate were generated from day 12.5 embryos
resulting from timed-pregnant heterozygous breedings and tissues
not used for culture were genotyped. The generation and
characterization of C6ko mice is described elsewhere [27]. Single
pups were dissected in ice cold PBS, the body without head, limbs
and liver, lung and heart was minced, the centrifuged pellet was
digested with 0.25% Trypsin-EDTA at 37uC for 15 min and
neutralized with MEF medium (Dulbecco’s modified Eagle
medium with high glucose, 10% fetal calf serum, 2 mM L-
Glutamine, 100 mM non-essential amino acids, 1 mM sodium
pyruvate, 1 mM b-mercaptoethanol). Cells were passaged through
a pipette tip, centrifuged and suspended in MEF medium
containing DNase I. After centrifugation, cells were suspended
in fresh medium, incubated for 2 min at room temperature to let
debris and cell clumps settle and cells in the supernatant were
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immortalized by transfection with pSV3-neo SV40 large T
antigen (ATCC) with the Fugene reagent (Roche) according to
manufacturer’s instructions. Immortalized cells were selected and
propagated through the addition of 600 mg/ml G418 to the
medium.
For the activation of caspase-6, cells were stressed with 50 nM
staurosporine for 0–6 h and harvested by trypsinization. Cell
pellets were lysed in 50 mM Tris pH 8, 150 mM NaCl and 1%
Igepal with 4.2 mM Pefabloc and ‘Complete’ protease inhibitor
cocktail (Roche) on ice, and protein concentrations were
determined in the cleared lysates after centrifugation.
Neuronal culture and lysis
Cortical neuronal cultures were prepared as described previ-
ously [38] from E16.5 littermate embryos obtained from timed-
pregnant heterozygous breedings and tissues not used for culture
were genotyped. Cultures were maintained at 37uC under 5%
CO2 and half of the culture media was exchanged every 4–5 days.
At day 10 in vitro,5mM camptothecin was added to the media to
induce caspase activation [39], and cells were harvested after 30 h
of treatment by scraping in ice-cold PBS supplemented with
protease inhibitors (4.2 mM Pefabloc and ‘Complete’ protease
inhibitor cocktail (Roche)). Cells were pelleted by centrifugation
and stored at –80uC until lysis. Cell pellets were lysed in 50 mM
HEPES pH 7.4, 100 mM NaCl, 1% Igepal, 1 mM EDTA and
10% glycerol with 4.2 mM Pefabloc and ‘Complete’ protease
inhibitor cocktail (Roche) on ice, and protein concentrations were
determined in the cleared lysates after centrifugation.
Culture, transfection and lysis of COS7 cells
COS7 cells were cultured in Dulbecco’s modified Eagle
medium supplemented with 10% fetal calf serum and 2 mM L-
Glutamine. Cells were transfected with human caspase-6 cDNA
with a C-terminal DDK tag using the Fugene reagent (Roche)
according to manufacturer’s instructions. Cells were harvested 0–
24 h after transfection by trypsinization. Cell pellets were lysed in
50 mM HEPES pH 7.4, 100 mM NaCl, 1% Igepal, 1 mM EDTA
and 10% glycerol with 4.2 mM Pefabloc and ‘Complete’ protease
inhibitor cocktail (Roche) on ice, and protein concentrations were
determined in the cleared lysates after centrifugation.
Culture and lysis of MCF-7 cells
MCF-7 cells were cultured in Dulbecco’s modified Eagle
medium supplemented with 10% fetal calf serum and 2 mM L-
Glutamine. Cells were stressed with 5 uM camptothecin for
different amounts of time and harvested by trypsinization. Cell
pellets were lysed in 50 mM HEPES pH 7.4, 100 mM NaCl, 1%
Igepal, 1 mM EDTA and 10% glycerol with 4.2 mM Pefabloc and
‘Complete’ protease inhibitor cocktail (Roche) on ice, and protein
concentrations were determined in the cleared lysates after
centrifugation.
Western blotting
20 ng of pure lamin A protein was subjected to digestion by
different concentrations of caspase-3, -6, and -7 (0.75–6 mM) in
caspase cleavage buffer for 30 min at 37uC. The reactions were
stopped by shock-freezing, and thawed samples were run on 4–
12% Bis-Tris gels (Nupage, Invitrogen), transferred to PVDF
membranes by electroblotting and membranes were developed
with primary antibodies in 5% BSA/PBS. Fluorescently labelled
secondary antibodies and the LiCor Odyssey Infrared Imaging
system were used for detection.
For Western blotting of cell lysates, 50 mg total protein were run
on 4–12% Bis-Tris gels (Nupage, Invitrogen) and processed as
described above.
Cell fixation and immunofluorescent staining
C6wt and C6ko MEFs were seeded at 2500 cells per well into
96well plates. N=3 for each treatment. The following day, cells
were treated with camptothecin (5 mM final) for 16 hours. Post
stress, cells were washed in PBS, fixed in 4% formaldehyde
(EMS)/PBS for 60 minutes at 4C, washed with PBS, and
permeabilized with 0.3% Triton-X 100/PBS. Primary antibody
to mouse cleaved lamin A (Cell Signaling Technology) was added
at 1:100, in normal goat serum, and incubated at 4C overnight.
Plates were washed twice in PBS before adding secondary
antibodies, AlexaFluor 488 anti-mouse IgG (Invitrogen), each at
1:800 in normal goat serum, and DNA staining dye, Hoechst
33342 (Invitrogen), at 1:10000, for 90 minutes at room temper-
ature. Plates were washed again twice and left in PBS.
Image capture and immunofluorescence data analysis
Labeled cells were analysed using the ThermoFisher Cellomics
ArrayScan VTI, a high content scanning (vHCS) microscope,
using version 6.6.2.0 software. The ArrayScan VTI captures
images using an ORCA-ER camera in two channels applicable to
the assay. XF-53 filters for 405 and 488 nm were used in
automated image analysis to quantify nuclei number, and cleaved
lamin A, respectively. The Cellomics toolbox, Compartmental
Analysis, used an algorithm to encircle perinuclear staining of
cleaved lamin A. The primary object in the Hoechst channel was
identified as the nucleus of the cell of which 500 total were counted
per well. In channels 2, the perinucleus was identified as a ‘‘circ’’,
which was 3 pixels outside the primary object, where the algorithm
measured pixel intensity above background staining. The
‘‘MEAN_AvgCirIntensity’’ for each channel was used for analysis,
under the vHCS analysis tool, and exported to Microsoft Excel
spreadsheets and GraphPad Prism for further analysis.
Supporting Information
Figure S1 Active site titrations for caspases -3, -6, 7. The
exact active site concentration of each caspase used was
determined by titrating the enzymes against the pan-caspase
inhibitor zVAD-fmk [27].
(TIF)
Figure S2 Km determination for lamin A. A: The
indicated concentrations of lamin A protein were digested with
20 nM caspase-6 and samples were analysed with the Mesoscale
ELISA system. B: Cleavage rates were determined as the slope of
the curves in (A) and plotted against the lamin A concentration to
obtain values for Km and kcat through curve fitting using the
built-in function of the GraphPad Prism 5.0 software package.
(TIF)
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